Cargando…
Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661391/ https://www.ncbi.nlm.nih.gov/pubmed/31078723 http://dx.doi.org/10.1016/j.jcmgh.2019.05.001 |
| _version_ | 1783439440488693760 |
|---|---|
| author | Goettel, Jeremy A. Kotlarz, Daniel Emani, Rohini Canavan, James B. Konnikova, Liza Illig, David Frei, Sandra M. Field, Michael Kowalik, Matthew Peng, Kaiyue Gringauz, Jordan Mitsialis, Vanessa Wall, Sarah M. Tsou, Amy Griffith, Alexandra E. Huang, Ying Friedman, Joshua R. Towne, Jennifer E. Plevy, Scott E. O’Hara Hall, Aisling Snapper, Scott B. |
| author_facet | Goettel, Jeremy A. Kotlarz, Daniel Emani, Rohini Canavan, James B. Konnikova, Liza Illig, David Frei, Sandra M. Field, Michael Kowalik, Matthew Peng, Kaiyue Gringauz, Jordan Mitsialis, Vanessa Wall, Sarah M. Tsou, Amy Griffith, Alexandra E. Huang, Ying Friedman, Joshua R. Towne, Jennifer E. Plevy, Scott E. O’Hara Hall, Aisling Snapper, Scott B. |
| author_sort | Goettel, Jeremy A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6661391 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66613912019-08-02 Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model Goettel, Jeremy A. Kotlarz, Daniel Emani, Rohini Canavan, James B. Konnikova, Liza Illig, David Frei, Sandra M. Field, Michael Kowalik, Matthew Peng, Kaiyue Gringauz, Jordan Mitsialis, Vanessa Wall, Sarah M. Tsou, Amy Griffith, Alexandra E. Huang, Ying Friedman, Joshua R. Towne, Jennifer E. Plevy, Scott E. O’Hara Hall, Aisling Snapper, Scott B. Cell Mol Gastroenterol Hepatol Research Letter Elsevier 2019-05-09 /pmc/articles/PMC6661391/ /pubmed/31078723 http://dx.doi.org/10.1016/j.jcmgh.2019.05.001 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Goettel, Jeremy A. Kotlarz, Daniel Emani, Rohini Canavan, James B. Konnikova, Liza Illig, David Frei, Sandra M. Field, Michael Kowalik, Matthew Peng, Kaiyue Gringauz, Jordan Mitsialis, Vanessa Wall, Sarah M. Tsou, Amy Griffith, Alexandra E. Huang, Ying Friedman, Joshua R. Towne, Jennifer E. Plevy, Scott E. O’Hara Hall, Aisling Snapper, Scott B. Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model |
| title | Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model |
| title_full | Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model |
| title_fullStr | Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model |
| title_full_unstemmed | Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model |
| title_short | Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model |
| title_sort | low-dose interleukin-2 ameliorates colitis in a preclinical humanized mouse model |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661391/ https://www.ncbi.nlm.nih.gov/pubmed/31078723 http://dx.doi.org/10.1016/j.jcmgh.2019.05.001 |
| work_keys_str_mv | AT goetteljeremya lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT kotlarzdaniel lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT emanirohini lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT canavanjamesb lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT konnikovaliza lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT illigdavid lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT freisandram lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT fieldmichael lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT kowalikmatthew lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT pengkaiyue lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT gringauzjordan lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT mitsialisvanessa lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT wallsarahm lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT tsouamy lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT griffithalexandrae lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT huangying lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT friedmanjoshuar lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT townejennifere lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT plevyscotte lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT oharahallaisling lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel AT snapperscottb lowdoseinterleukin2amelioratescolitisinapreclinicalhumanizedmousemodel |